<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02284711</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL14_0166</org_study_id>
    <secondary_id>2014-A01218-39</secondary_id>
    <nct_id>NCT02284711</nct_id>
  </id_info>
  <brief_title>Impact of Salpingectomy on Ovarian Reserve</brief_title>
  <acronym>SALPOVA</acronym>
  <official_title>Impact of Salpingectomy on Ovarian Reserve, With Comparison Between Two Coagulation Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epithelial cancer of the ovaries is the most severe form of gynecologic cancer; a significant&#xD;
      proportion of ovarian cancers originate from the Fallopian tube. Guidelines therefore now&#xD;
      recommend systematically associating prophylactic salpingectomy to benign hysterectomy. The&#xD;
      principal objective of the present study is to assess the impact of salpingectomy on ovarian&#xD;
      reserve by anti-Müllerian hormone (AMH) assay and calculating the Doppler index of vascular&#xD;
      resistance in the ovarian vessels. The secondary objective is to compare ovarian reserve&#xD;
      results between two coagulation techniques used in salpingectomy: bipolar electric energy&#xD;
      versus ultrasound.&#xD;
&#xD;
      The study design is single-center, prospective, before-and-after, with open randomization&#xD;
      between two groups defined by coagulation technique.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 9, 2015</start_date>
  <completion_date type="Actual">October 16, 2020</completion_date>
  <primary_completion_date type="Actual">October 16, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>AMH level</measure>
    <time_frame>3 months post-surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AMH level</measure>
    <time_frame>1 month post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>index of vascular resistance in the ovarian vessels</measure>
    <time_frame>1 and 3 months post-surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>menopausal quality of life score</measure>
    <time_frame>1 and 3 months post-surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Laparoscopic Salpingectomy</condition>
  <arm_group>
    <arm_group_label>Bipolar</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coagulation during salpingectomy using conventional bipolar electric energy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Coagulation during salpingectomy using UltraCision HARMONIC ACE® ultrasound energy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bipolar electric energy</intervention_name>
    <description>Coagulation during salpingectomy using conventional bipolar electric energy</description>
    <arm_group_label>Bipolar</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ultrasound energy</intervention_name>
    <description>Coagulation during salpingectomy using UltraCision HARMONIC ACE® ultrasound energy</description>
    <arm_group_label>Ultrasound</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female subjects aged 18&#xD;
&#xD;
          -  Scheduled surgery: bilateral laparoscopic salpingectomy associated to hysterectomy for&#xD;
             benign indication&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Interview revealing disorder entailing unacceptable risk of postoperative&#xD;
             complications: coagulation disorder, immune system disorder, evolutive disease, etc.&#xD;
&#xD;
          -  Pregnancy, ongoing or planned during the study period&#xD;
&#xD;
          -  History of bilateral salpingectomy&#xD;
&#xD;
          -  Salpingectomy associated with pelvic cancer&#xD;
&#xD;
          -  Oral hormonal contraception during the study period&#xD;
&#xD;
          -  Menopause&#xD;
&#xD;
          -  Inability to understand information provided&#xD;
&#xD;
          -  Not covered by a national health insurance scheme, prisoner or under administrative&#xD;
             supervision.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - HFME</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 4, 2014</study_first_submitted>
  <study_first_submitted_qc>November 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2014</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>salpingectomy, ovarian reserve, coagulation technique</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

